Anaptysbio (ANAB) Revenue (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.93% |
| Dec 31, 2025 | 50.00% |
| Sep 30, 2025 | 124.59% |
| Jun 30, 2025 | -19.83% |
| Mar 31, 2025 | 11.08% |
| Dec 31, 2024 | 66.67% |
| Sep 30, 2024 | 36.72% |
| Jun 30, 2024 | 52.82% |
| Mar 31, 2024 | -20.28% |
| Dec 31, 2023 | 171.40% |
| Sep 30, 2023 | -4.10% |
| Jun 30, 2023 | 151.82% |
| Mar 31, 2023 | -72.52% |
| Dec 31, 2022 | 286.70% |
| Sep 30, 2022 | 6.33% |
| Jun 30, 2022 | 25.36% |
| Mar 31, 2022 | -4.06% |
| Dec 31, 2021 | -94.95% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 100.00% |
| Mar 31, 2021 | -83.33% |
| Mar 31, 2020 | 233.33% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | -75.00% |
| Jun 30, 2016 | 0.00% |